Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00608296 · ClinicalTrials.gov registry record
Functional and Neurochemical Brain Changes Bipolar Depression
A clinical trial of Depression, Bipolar, sponsored by University of Cincinnati.
- Completed
- Registry status
- 120
- Enrollment target
- 1
- Study location
NCT00608296: Completed study of Depression, Bipolar, sponsored by University of Cincinnati.
NCT00608296 is a study of Depression, Bipolar that has completed, run by University of Cincinnati. The registered enrollment target is 120 participants, below the 704-participant average among 5 other Depression, Bipolar trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00608296, a study of Depression, Bipolar, has completed, sponsored by University of Cincinnati.
- COMPLETED
- Registry status
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the research is to study brain structure, function and chemistry of patients with bipolar disorder who are receiving quetiapine or lithium, in order to better understand who benefits from treatment and why they respond to medications.
Conditions Studied
Study Locations (1)
Ohio
- University of Cincinnati - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2008-01 |
| Est. Completion | 2013-07 |
What the finished NCT00608296 record still lists
NCT00608296 is an observational study that tracks outcomes without assigning an intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 704-participant average among 5 other Depression, Bipolar trials with a reported enrollment target (83% lower).
The record links to 1 condition, with Depression, Bipolar appearing as the primary indexed condition, and to 0 interventions.
NCT00608296 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT00608296 about?
NCT00608296 is a clinical study titled "Functional and Neurochemical Brain Changes Bipolar Depression". The purpose of the research is to study brain structure, function and chemistry of patients with bipolar disorder who are receiving quetiapine or lithium, in order to better understand who benefits from treatment and why they respond to medications.
What is the current status of trial NCT00608296?
This trial is currently completed. The enrollment target is 120 participants. The study started on 2008-01. Estimated completion is 2013-07.
What conditions does trial NCT00608296 study?
This clinical trial studies the following conditions: Depression, Bipolar.
Who is sponsoring clinical trial NCT00608296?
This trial is sponsored by University of Cincinnati, which has 245 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00608296 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression, Bipolar
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Acceptability & Safety of Two Sequential Doses of Psilocybin in Bipolar Disorder II Depression and Suicidality
RECRUITING · Phase 2
-
Dallas 2K: A Natural History Study of Depression
RECRUITING
-
Depakote ER in Bipolar Depression
COMPLETED · Phase 4
-
Phase III/Seroquel SR Bipolar Depression Monotherapy - US
COMPLETED · Phase 3
-
Safety, Tolerability, and Efficacy of Cariprazine in Participants With Bipolar Depression
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia